Lumeon provides a Care Pathway Management (CPM) platform that automates patient care coordination to improve care quality and reduce costs. The platform uses real-time data to dynamically guide patients and care teams along care journeys and automates, orchestrates and virtualizes care delivery across settings. It integrates with all electronic health record (EHR) systems and ingests required clinical and administrative data from point solutions and devices to address fragmentation and interoperability challenges. More than 70 health systems across 12 countries have deployed Lumeon’s platform. The company intends to use the new funding to extend the reach of its platform. Lumeon is led by founder and CEO Robbie Hughes and is based in Boston, MA. Lumeon’s core product is its Care Pathway Management (CPM) platform, which deploys personalized care pathways combining intelligent orchestration, automation and advanced patient engagement. The platform builds on existing Electronic Health Records (EHR) to eliminate low-value activities, assure best practice, reduce operational costs and improve the patient experience while increasing revenue. Lumeon serves large health enterprises globally and manages over six million patients on its platform. The company positions CPM as an enterprise-wide capability for hospital CIOs rather than a set of point solutions. Lumeon has headquarters in the USA and Europe, with a Boston presence, and is focused on accelerating penetration in the U.S. market. The company recently secured new capital to scale commercial operations and accelerate customer deployments in the region. Qinec is a UK-based digital health company that offers Personalized Healthcare Management (PHM) via a cloud-based SaaS platform. The platform uses real-time data to orchestrate and tailor patient journeys, optimizing clinical and administrative workflows across outpatient specialties. Qinec supports millions of patient journeys a year across Europe and counts customers including Alliance Medical and Optegra Eye Health Care. The company says its solution improves outcomes for patients, providers and payers while reducing costs. Qinec will use the new funding to scale the team and further expand within a Healthcare IT market segment the article cites as predicted to be worth over $1.3 billion. The company is also strengthening its executive team with the appointment of Andrew Wyatt as Chief Operating Officer. Qinec is a web-based medical practice management platform that helps outpatient providers run appointments, records, prescribing and billing. It offers patient-facing iPad apps and has secured distribution and licensing agreements outside the UK, including in the US. The product targets outpatient care providers such as ophthalmologists and physiotherapists and was recently selected as the cloud platform for the UK outpatient network of a major blue-chip international insurer and healthcare provider. The company positions itself as a ‘Salesforce for doctors’ and aims to connect outpatient care to improve processes and outcomes. Qinec is led by CEO Robbie Hughes, who highlighted the opportunity to transform the economics of healthcare through joined-up, connected outpatient provision. The company recently completed new investor financing described below.

Total raised

$70M

Funding rounds

4

Latest round

Series D

Latest activity

Aug 2020